デフォルト表紙
市場調査レポート
商品コード
1566131

塞栓防止装置の市場規模、シェア、成長分析、タイプ別、材料別、適応症別、用途別、地域別 - 産業予測、2024年~2031年

Embolic Protection Devices Market Size, Share, Growth Analysis, By Type, By Material, By Indication, By Application, By Region - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
塞栓防止装置の市場規模、シェア、成長分析、タイプ別、材料別、適応症別、用途別、地域別 - 産業予測、2024年~2031年
出版日: 2024年10月03日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の塞栓防止装置の市場規模は、2022年に5億5,455万米ドルとなり、2023年の6億488万米ドルから、2031年までには11億4,641万米ドルに成長し、予測期間(2024年~2031年)のCAGRは8.32%で成長する見通しです。

塞栓防止装置の世界市場は、医療機器業界の中でも急成長している分野であり、血栓や血片が外れて血流にのって移動し、重要な臓器に閉塞を引き起こす可能性のある状態である塞栓の予防に焦点を当てています。これらの機器は、経カテーテル的大動脈弁置換術(TAVR)、頸動脈ステント留置術、経皮的冠動脈インターベンション(PCI)などの様々な侵襲的心血管系処置の際に、これらの塞栓を捕捉・除去するように設計されています。市場は、心血管疾患の有病率の増加、高齢者人口の増加、低侵襲手技の採用拡大などの要因によって牽引されています。新規フィルターデザイン、生体吸収性フィルター、遠位閉塞システムの開発など、塞栓防止装置における技術的進歩が市場成長をさらに後押ししています。さらに、塞栓防止装置の特典や手技合併症の軽減に対する医療従事者の意識の高まりが、採用の増加に繋がっています。市場競争は激しく、複数の主要企業がこれらの機器の開発と販売に携わっています。地域別では北米が大きなシェアを占めており、次いで欧州、アジア太平洋、その他地域の順となっています。世界の塞栓防止装置市場は、技術の進歩、ヘルスケア支出の増加、新興国における低侵襲手術の需要の高まりなどを背景に、今後も上昇基調を維持すると予想されます。

米国の塞栓防止装置市場は、先進医療技術への需要増と心血管疾患の有病率上昇に牽引され、今後予測期間も安定した成長が見込まれます。ヘルスケアプロバイダーや施設は、心血管インターベンションなどの処置中の患者の安全性を優先し続けるため、塞栓防止装置の統合は不可欠となっています。高齢者人口の増加と低侵襲手術の急増は、市場拡大にさらに拍車をかけています。さらに、機器のデザインや機能における技術的進歩、革新的な製品に対する規制当局の承認が、市場のダイナミクスを高めると予想されます。これらの要因が相まって、米国の塞栓防止装置市場の有望な軌道が示され、持続可能なCAGRが投資や研究イニシアチブを引き付け、最終的には心臓血管手術における患者の転帰を改善することが期待されます。業界情勢が進化する中、ヘルスケア分野の利害関係者は、医療機器業界の重要なセグメントであるこの市場において、成長とイノベーションの機会を活用するために、これらの動向に注意を払い続ける必要があります。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主要な市場の考察

  • 主要な成功要因
  • 競合の程度
  • 主要な投資機会
  • 市場のエコシステム
  • 規制情勢
  • 技術分析
  • 特許分析
  • バリューチェーン分析

塞栓防止装置市場:タイプ別

  • 市場概要
  • 遠位フィルター装置
  • 遠位閉塞装置
  • 近位閉塞装置

塞栓防止装置市場:材料別

  • 市場概要
  • ニチノール
  • ポリウレタン

塞栓防止装置市場:適応症別

  • 市場概要
  • 経皮的冠動脈インターベンション
  • 頸動脈疾患
  • 伏在静脈移植疾患
  • 経カテーテル大動脈弁置換術
  • その他の適応症

塞栓防止装置市場:用途別

  • 市場概要
  • 心血管疾患
  • 神経血管疾患
  • 末梢血管疾患

塞栓防止装置市場:エンドユーザー別

  • 市場概要
  • 病院
  • 外来手術センター

塞栓防止装置市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • Contego Medical
  • Silk Road Medical
  • Claret Medical
  • Allium Medical Solutions
  • Edwards Lifesciences
  • Healthcare Solutions Holding, LLC
  • Innovative Cardiovascular Solutions, LLC
  • Transverse Medical, Inc.
  • Keystone Heart Ltd.
  • InspireMD, Inc.
  • AngioDynamics, Inc.
  • Emboline, Inc.
  • Acandis GmbH & Co. KG
  • Veryan Medical Ltd.
  • Shanghai MicroPort Medical Co., Ltd.
  • MedNova, Inc.
目次
Product Code: SQMIG35A2683

Global Embolic Protection Devices Market size was valued at USD 554.55 million in 2022 and is poised to grow from USD 604.88 million in 2023 to USD 1146.41 million by 2031, growing at a CAGR of 8.32% during the forecast period (2024-2031).

The Global Embolic Protection Devices Market is a rapidly growing sector in the medical device industry that focuses on preventing embolization, a condition where blood clots or debris dislodge and travel through the bloodstream, potentially causing blockages in vital organs. These devices are designed to capture and remove these emboli during various invasive cardiovascular procedures, such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI). The market is being driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and the growing adoption of minimally invasive procedures. Technological advancements in embolic protection devices, such as the development of novel filter designs, bioresorbable filters, and distal occlusion systems, are further propelling market growth. Additionally, the rising awareness among healthcare professionals regarding the benefits of embolic protection devices and the need for reducing procedural complications has led to increased adoption. The market is highly competitive, with several key players involved in the development and distribution of these devices. Geographically, North America currently holds a significant share in the market, followed by Europe, Asia Pacific, and the rest of the world. The Global Embolic Protection Devices Market is expected to continue its upward trajectory in the coming years, driven by technological advancements, increasing healthcare expenditure, and a rising demand for minimally invasive procedures in emerging economies.

The US Embolic Protection Devices Market is expected to experience stable growth over the upcoming forecast period, driven by increasing demand for advanced medical technologies and rising prevalence of cardiovascular diseases. As healthcare providers and facilities continue to prioritize patient safety during procedures such as cardiovascular interventions, the integration of embolic protection devices is becoming essential. The growing geriatric population, coupled with a surge in minimally invasive surgeries, is further fueling market expansion. Additionally, technological advancements in device design and function, as well as regulatory approvals for innovative products, are expected to enhance market dynamics. These factors collectively signal a promising trajectory for the US Embolic Protection Devices Market, indicating a sustainable compound annual growth rate (CAGR) that will attract investment and research initiatives, ultimately improving patient outcomes in cardiovascular procedures. As the landscape evolves, stakeholders in the healthcare sector must remain attuned to these trends to leverage opportunities for growth and innovation in this critical segment of the medical device industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the The Global Embolic Protection Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The Global Embolic Protection Devices Market Segmental Analysis

Global Embolic Protection Devices Market is segmented by Type, Material, Indication, Application, End User, and Region. Based on Type, the market is segmented into Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices. Based on Material, the market is segmented into Nitinol, Polyurethane. Based on Indication, the market is segmented into Percutaneous Coronary Intervention, Carotid Artery Diseases, Saphenous Vein Graft Disease, Transcatheter Aortic Valve Replacement, Other Indications. Based on Application, the market is segmented into Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the The Global Embolic Protection Devices Market

The increasing prevalence of cardiovascular diseases is a significant market driver for the Global Embolic Protection Devices Market. As conditions like coronary artery disease, peripheral artery disease, and valvular heart disease become more common globally, the demand for advanced embolic protection devices intensifies. These devices are essential in mitigating complications during invasive cardiovascular interventions, such as stent placements and angioplasty, thereby enhancing overall patient safety and outcomes. Moreover, the growing awareness of the benefits of employing these protective devices in clinical settings further propels their adoption, ultimately fueling market growth as healthcare providers aim to improve procedural success rates and reduce associated risks.

Restraints in the The Global Embolic Protection Devices Market

A significant market restraint for the Global Embolic Protection Devices market is the high cost of these technologies, which can impede their adoption, especially in emerging economies with constrained healthcare budgets. The substantial financial investment required for these devices, coupled with the need for specialized training and expertise for their effective application, creates barriers to entry and limits accessibility in certain regions. Consequently, this financial hurdle may inhibit widespread utilization and growth of the market. To counteract this issue, initiatives aimed at enhancing cost-effectiveness, alongside improved reimbursement frameworks, are essential for promoting broader acceptance and integration of embolic protection devices.

Market Trends of the The Global Embolic Protection Devices Market

The Global Embolic Protection Devices market is witnessing a significant trend driven by the increasing adoption of minimally invasive procedures across various medical specialties. Techniques such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI) are becoming preferred options due to their benefits, including shorter hospital stays, quicker recovery times, and reduced complication rates when compared to traditional surgical methods. Consequently, there is a heightened demand for advanced embolic protection devices that effectively minimize the risk of emboli during these procedures. This trend is propelling innovation, with manufacturers focusing on developing specialized devices tailored for minimally invasive interventions, aligning with the changing preferences of healthcare providers and patients.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Regulatory Landscape
  • Technology Analysis
  • Patent Analysis
  • Value Chain Analysis

Embolic Protection Devices Market, By Type

  • Market Overview
  • Distal Filter Devices
  • Distal Occlusion Devices
  • Proximal Occlusion Devices

Embolic Protection Devices Market, By Material

  • Market Overview
  • Nitinol
  • Polyurethane

Embolic Protection Devices Market, By Indication

  • Market Overview
  • Percutaneous Coronary Intervention
  • Carotid Artery Diseases
  • Saphenous Vein Graft Disease
  • Transcather Aortic Valve Replacement
  • Other Indications

Embolic Protection Devices Market, By Application

  • Market Overview
  • Cardiovascular Diseases
  • Neurovascular Diseases
  • Peripheral Vascular Diseases

Embolic Protection Devices Market, By End User

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers

Embolic Protection Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Contego Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Silk Road Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Claret Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allium Medical Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Healthcare Solutions Holding, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innovative Cardiovascular Solutions, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Transverse Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Keystone Heart Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InspireMD, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Emboline, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acandis GmbH & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Veryan Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai MicroPort Medical Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedNova, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments